Cargando…
Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance
Antibiotic resistance is one of the most important challenges of the 21(st) century. However, the growing understanding of bacterial pathogenesis and cell-to-cell communication has revealed many potential strategies for the discovery of drugs that can be used for the treatment of bacterial infection...
Autores principales: | Abd El-Aleam, Rehab H., George, Riham F., Georgey, Hanan H., Abdel-Rahman, Hamdy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043591/ https://www.ncbi.nlm.nih.gov/pubmed/35494393 http://dx.doi.org/10.1039/d1ra06238g |
Ejemplares similares
-
Nano-MOFs as targeted drug delivery agents to combat antibiotic-resistant bacterial infections
por: Ahmed, Saleh A., et al.
Publicado: (2020) -
IR780 Based Sonotherapeutic Nanoparticles to Combat Multidrug-Resistant Bacterial Infections
por: Huang, Biying, et al.
Publicado: (2022) -
Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review
por: Mansour, Mostafa A., et al.
Publicado: (2023) -
Effectiveness of some novel heterocyclic compounds as corrosion inhibitors for carbon steel in 1 M HCl using practical and theoretical methods
por: Fouda, Abd El-Aziz S., et al.
Publicado: (2021) -
Anti-inflammatory Activity and PGE(2) Inhibitory Properties of Novel Phenylcarbamoylmethyl Ester-Containing Compounds
por: Barsoum, Flora, et al.
Publicado: (2009)